OR WAIT null SECS
Industry news focusing on the people and organizations who work in the clinical trials profession.
• Southern Research Institute (Birmingham, AL) announced that Damon Papac, PhD, and Joseph Murphy, PhD, have joined the not-for-profit research organization to lead two key departments within its Drug Development Division, a technology group that primarily provides contract preclinical drug development services for the pharmaceutical industry and government clients.
Damon Papac, PhD
• Premier Research Group (Philadelphia, PA) has appointed Etienne Drouet to the position of Executive Director, Oncology Europe.
• ACR Image Metrix (Philadelphia, PA) has appointed seven scientific and business leaders to its board of directors including Paul Ellenbogen, MD, Chairman of the ACR Image Metrix Board of Directors, Partner at Radiology Associates of North Texas; Jonathan Lewin, MD, Chairman, Department of Radiology and Radiological Science at Johns Hopkins University and Radiologist-in-Chief at Johns Hopkins Hospital; and Harvey Neiman, MD, Chief Executive Officer at ACR Image Metrix and Executive Director of American College of Radiology. In addition, Donald Rosen, MD, Co-Founder of RadPharm, Inc.; Samuel Broder, MD, Former Vice President and CMO of Celera; Carolyn Meltzer, MD, Chair of the Department of Radiology at Emory University School of Medicine; and Joel Morganroth, MD, Chief Scientific Officer at ERT, have been appointed to the board of directors.
Paul Ellenbogen, MD
• invivodata (Pittsburgh, PA) has appointed Wolfgang Summa, PhD, Vice President of Worldwide Operations. Working out of invivodata's headquarters in Pittsburgh, Summa will be responsible for managing the successful implementation of invivodata's ePRO solutions in clinical trials around the world.
Wolfgang Summa, PhD
• Clinipace Worldwide (Morrisville, NC) announced the addition of John Larus as Executive Vice President of Clinical Operations, to its growing team of clinical development experts.
• Covance has appointed Raymond Kaiser, PhD, as the new Global Science Leader and Vice President for Biotechnology Services. Kaiser will replace Carl Martin, PhD.
• John Potthoff, PhD has been appointed as Theorem Clinical Research's (King of Prussia, PA) President and CEO. He succeeds James M. Pusey, MD, who has been elevated to Executive Chairman to the Board of Directors. In addition, Adam Serody (King of Prussia, PA) has joined the company as Vice President, Global Business Development and Marc Hoffman, MD, has joined the company as Senior Vice President and General Manager for its newly formed Pharmaceutical Development Business Unit. Christian Tucat has been appointed Vice President and General Manager, Europe, Middle East, and Africa.
• With more than 18 years of experience, Li Liu, PhD, has joined Frontage Laboratories (Exton, PA) as Executive Director, Biometrics, responsible for Biometrics Services.
Bringing 23 years experience within the pharmaceutical and CRO industry, Steve Cutler, PhD, has joined ICON (Dublin, Ireland) as Group President, Clinical Research Services.
• BioPharm Systems (San Mateo, CA) has named Rudolf Coetzee as Director of Business Development for the Europe, Middle East, and Africa region.
• DaVita Labs (Fort Lauderdale, FL) has hired Leslie Mirani as the company's new Vice President and General Manager.
• Quintiles (Research Triangle Park, NC) has acquired Outcome Sciences, Inc., a privately held outcomes research firm headquartered in Cambridge, MA.
• Aptiv Solutions (Reston, VA) has acquired SRA Global Clinical Development, the CRO division of SRA International, Inc. based in Durham, NC, with offices in Paris, France and Milton Park, England.
• INC Research (Raleigh, NC) and SAS (Cary, NC) are working together to improve clinical development risk management and achieve targeted product profiles through analytics. They will offer biopharmaceutical customers an integrated suite of tools to increase decision-making speed, efficiency, and flexibility.
• ICON (Dublin, Ireland) and Empire Genomics (Buffalo, NY) announced the formation of a strategic alliance to develop a service portfolio tailored to the development of personalized medicines.
• TAKE Solutions (Princeton, NJ) has partnered with MENE Research (Istanbul, Turkey) and together will cater to the Drug Safety requirements of Middle East, Europe, and West Asian countries.
• Alquest (Northwood, OH) has become the first organization to join MedNet Solutions' (Minnetonka, MN) iMedNet CRO Partner Program.
• Boehringer Ingelheim (Ingelheim am Rhein, Germany) has awarded Patheon (Toronto, Canada) two projects with combined revenue of more than $18 million over a three-year period. The projects are both fixed-dose combination drugs in development for the treatment of the growing population of type II diabetics.
• Exco InTouch (Sawbridgeworth, UK) has received the European Outsourcing Awards held in Frankfurt. Exco InTouch has been honored with the accolade of "Best eBusiness/IT Strategy," which recognizes Exco InTouch's collaboration with Pfizer.
Exco InTouch Wins Best eBusiness/IT Strategy Award at European Outsourcing Awards 2011 in Frankfurt, Germany. The company has been awarded the title "Best eBusiness/IT Strategy," which recognizes Exco InTouch’s collaboration with Pfizer.
• INTERLAB Central Lab Services—Worldwide (Munich, Germany) has been awarded with the Exportpreis Bayern 2011, the Bavarian Prize for Export Achievements in the Services Sector by the Bavarian Minister of Economy and Technology.
• Drug Safety Alliance (Research Triangle Park, NC) has been named a winner in the Triangle Business Journal's "Fast 50" awards for the third straight year. Given to the 50 fastest growing privately held companies in North Carolina's Triangle region, the award honors businesses for their contributions to the growth and success of the community.
• Copernicus Group IRB (Research Triangle Park, NC) has been named a finalist in Training Magazine's annual Top 125, which ranks companies' excellence in employer-sponsored training and development programs.
• Eurofins Global Central Laboratory has opened a new Central Laboratory in Bangalore, India.
• Almac has announced the expansion of its Pharmaceutical Development services with the creation of a new facility at its UK headquarters in Craigavon.
• ICON's (Dublin, Ireland) resourcing division, DOCS, has expanded in Europe by opening four new offices in Milan, Italy; Budapest, Hungary; Brussels, Belgium; and Berlin, Germany.
• Cmed Technology (New Providence, NJ) has launched Timaeus Guided Trial Builder, a new product that introduces a different approach to reduce the time and effort required to start up electronic trials.
• Almac (Craigavon, Northern Ireland) has released its new forecasting platform, COMPASS, which has been designed to improve the accuracy and efficiency of the supply inventory process during clinical studies.